本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

98.64
-0.6550-0.66%
成交量:11.46萬
成交額:1,124.62萬
市值:195.47億
市盈率:-16.58
高:98.98
開:97.97
低:97.91
收:99.29
52周最高:124.49
52周最低:29.17
股本:1.98億
流通股本:1.79億
量比:1.37
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-5.9502
淨資產收益率:-58.07%
總資產收益率:-30.08%
市淨率:11.98
市盈率(LYR):-16.58

資料載入中...

2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities